Steve Deitsch

Steve Deitsch is an accomplished finance executive with extensive experience in the healthcare and technology sectors. Currently serving as Chief Financial Officer at OrganOx since April 2024, Deitsch is instrumental in innovating organ preservation technology. In addition, Deitsch holds board positions at Aclarion and Auddia, contributing to advancements in healthcare technology and audio engagement, respectively. Previously, Deitsch served as CFO for Paragon 28, leading a successful NYSE IPO, and held CFO roles at BioScrip and Coalfire, where significant mergers and acquisitions were achieved. Deitsch's background includes senior finance positions at Zimmer Biomet and experience with EY, enhancing financial strategies for leading organizations. Deitsch earned a Bachelor of Science degree in Accounting from Ball State University.